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A B S T R A C T
The differentiation of patient-specific induced pluripotent stem cells (iPSCs) into specific neuronal subtypes has
been exploited as an approach for modeling a variety of neurological disorders. However, achieving a highly
pure population of neurons is challenging when using directed differentiation methods, especially for neuronal
subtypes generated by complex and protracted protocols. In this study, we efficiently produced highly pure
populations of regionally specified CNS neurons by using a modified NGN2-Puromycin direct conversion pro-
tocol. The protocol is amenable across a range of iPSC lines, with more than 95% of cells at day 21 positive for
the neuronal marker MAP2. We found that conversion from pluripotent stem cells resulted in neurons from the
central and peripheral nervous system; however, by incorporating a short CNS patterning step, we eliminated
these peripheral neurons. Furthermore, we used the patterning step to control the rostral-caudal identity. This
approach of sequential patterning and conversion produced pure populations of forebrain neurons, when pat-
terned with SMAD inhibitors. Additionally, when SMAD inhibitors and WNT agonists were applied, the approach
produced anterior hindbrain excitatory neurons and resulted in a neuronal population containing VSX2/SHOX2
V2a interneurons. Overall, this sequential patterning and conversion protocol can be used for the production of a
variety of CNS excitatory neurons from patient-derived iPSCs, and is a highly versatile system for investigating
early disease events for a range of neurological disorders including Alzheimer’s disease, motor neurons disease
and spinal cord injury.
1. Introduction
Since the derivation of induced pluripotent stem cells (iPSCs), pa-
tient-specific iPSCs have been produced from a broad range of patients
with sporadic or familial forms of neurological diseases. When com-
bined with gene editing techniques to correct or introduce mutations,
the diseased and isogenic iPSCs can be used together to investigating
disease mechanisms in vitro. A constant focus in the field has, therefore,
been towards the development of differentiation protocols that can
more closely recapitulate sequential in vivo patterning events and direct
cell fate towards specific brain regions, in order to generate appropriate
neuronal subtypes for modeling a neurological disease (Arenas et al.,
2015; Davis-Dusenbery et al., 2014). One of the current challenges in
the field is that directed differentiation protocols take several weeks or
even months to produce high percentages of post-mitotic neurons, the
cells become more asynchronous as the protocol becomes more pro-
tracted, and cultures come to contain varying amounts of progenitor
cells at differing maturity. These restraints hamper the use of high-
throughput analyses or sequencing methods. Several approaches have
been adopted to remove progenitors or accelerate their differentiation
to a mature neuronal state. However, accelerated differentiation using
various combinations of inhibitors has only been successful at produ-
cing a limited range of neuronal subtypes of either forebrain or sensory
neurons, depending on the inhibitors used (Chambers et al., 2012; Qi
et al., 2017; Telezhkin et al., 2016).
An alternative to directed differentiation is direct reprogramming,
which can be performed from fibroblasts or other somatic cells and is
capable of directly generating post-mitotic neurons (Ambasudhan et al.,
2011; Chanda et al., 2014; Vierbuchen et al., 2010). Applying this
method to pluripotent stem cells overcomes limitations in the
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availability of precious patient cells and, when combined with a re-
sistance gene to select for transgene expression, the method can result
in a highly pure population of excitatory neurons (Chanda et al., 2014;
Pang et al., 2011; Thoma et al., 2012; Zhang et al., 2013). Conversion to
alternate neuronal lineages can also be achieved by supplementing the
neuronal conversion genes with lineage-specific transcription factors.
However, the inclusion of multiple conversion factors to generate al-
ternate neuronal subtypes introduces additional inefficiencies and re-
quires an understanding of which transcription factor determinants are
specifically required for each lineage (Blanchard et al., 2014; Pfisterer
et al., 2011; Son et al., 2011; Theka et al., 2013). Having the ability to
directly convert cells to a broader range of neurons without the need to
identify a specific transcription factor determinate would considerably
increase the applicability of direct conversion as a method to generate
neurons for disease modeling.
In this study, we sought to develop a platform for converting iPSCs
into region-specific neurons. By combining the early patterning events
of a differentiation protocol with a direct conversion approach, we
produced highly pure, regionally specified induced neurons (iNs). To
achieve this, we began by optimising an NGN2-Puromycin direct con-
version protocol to produce pure populations of excitatory neurons. We
demonstrated that optimisation of the antibiotic selection period and
concentration enables highly pure neuronal cells to be obtained, and
the addition of mitotic inhibitors can be avoided, resulting in a protocol
that is amenable across a broad range of iPSC lines. Interestingly, the
NGN2-conversion from the pluripotent state yielded a mixed neuronal
culture containing a significant number of peripheral neurons. To
overcome this and have the ability to control the differentiation to-
wards specific central nervous system (CNS) fates, we incorporated a
short differentiation-patterning step that successfully prevented the
generation of peripheral neurons. By using factors known to alter the
rostral-caudal identity, we successfully specified the neurons to specific
brain regions and produce pure populations of either forebrain or
anterior hindbrain excitatory neurons. Thus, this approach can produce
regionally specified post-mitotic CNS excitatory neurons from patient-
derived iPSCs, which stands as a highly relevant system for in-
vestigating a range of neurological disorders.
2. Materials and methods
2.1. Human pluripotent stem cell culture
The following iPSCs lines were used in this study: CCD-001-C3
(DANi-001C), GBA-002-C3 (DANi-002C), GBA-003-C8 (DANi-003H),
PRKN-004-C1 (DANi-004A), LRRK2-GBA-005-C1 (DANi-005A), GBA-
006-C6 (DANi-006F), PINK1-007-C1 (DANi-007A), SNCA-008-C6
(DANi-008F), SNCA-009-C3 (DANi-009C), GBA-010-C1 (DANi-010A),
LRRK2-011-C1 (DANi011-A) (Chen et al., 2020a, 2020b). Additionally,
human embryonic stem cells (hESCs) H9 (WA-09, WiCell) were in-
cluded. Pluripotent stem cells were cultured on irradiated human
foreskin fibroblasts (HFF; ATCC CRL-2097) in KSR media consisting of
DMEM/nutrient mixture F-12, supplemented with β-mercaptoethanol
0.1 mM, non-essential amino acids (NEAA) 1%, glutamine 2 mM, pe-
nicillin 25 U/ml, streptomycin 25 U/ml and knockout serum replace-
ment 20% (all from Life Technologies), supplemented with FGF2
(15 ng/ml; Peprotech) and Activin A (15 ng/ml; R&D systems). Co-
lonies were mechanically dissected every 7 days and transferred to
freshly prepared HFF. Media was changed every second day. Prior to
differentiation, PSCs were expanded feeder-free in TESR-E8 media on
Vitronectin XF™ (STEMCELL Technologies). All cells were cultured at
37 °C and 5% CO2.
2.2. Lentiviral production
Lentiviruses were produced in HEK293T/17 (ATCC; CRL-11268)
cells by co-transfection with three plasmids: a packaging plasmid
(psPAX2), envelope plasmid (pMD2.G) and a vector plasmid (FUW-
M2rtTA or pTet-O-Ngn2-puro or pTet-O-NGN2-puro-GFP) all acquired
from Addgene (12260, 12259, 20342, 52047, 79823, respectively).
15 μg of packaging plasmid, 5 μg of envelope plasmid, 20 μg of vector
plasmid were transfected per 55 cm2 culture dish using Lipofectamine
3000 (Life Technologies). Viral supernatant was harvested with DMEM
medium supplemented with 5% KSR, 1% glutamax, 1% penicillin/
streptomycin, 0.5% HEPES (all from Life Technologies) over two days.
On the second day, viral supernatant was centrifuged for 10 min at
500g and filtered through a 0.45 µm filter and pelleted by ultra-
centrifugation (91,000 g for 90 min at 4 °C) through a sucrose cushion
(20% sterile sucrose in TNE buffer containing 50 mM Tris-HCl (pH 7.4),
100 mM NaCl, 0.5 mM ethylenediaminetetraacetic acid (EDTA)). Then,
the viral pellets were resuspended in ice-cold Neurobasal medium (Life
Technologies), aliquoted and frozen on dry-ice, stored at −80 °C for
future use.
2.3. Direct conversion of human ESCs and iPSCs into induced neurons (iNs)
Human ESCs or iPSCs were expanded on a Vitronectin-coated
(STEMCELL Technologies) 35 mm diameter Petri dish (Thermo scien-
tific) in TeSRTM-E8TM basal medium (STEMCELL Technologies). When
the cells reached 70–80% confluence, they were dissociated with Gentle
Cell Dissociation Reagent (STEMCELL Technologies), and Y-27632
(10 μM, Tocris Bioscience) was added to the medium for 12 h post-
dissociation. The protocol of direct conversion of human ESCs and
iPSCs into induced neurons (iNs) is shown in Fig. 1A. Two days before
neural conversion (day −2), 250,000 cells of H9 or iPSCs were plated
on a Vitronetin-coated 35 mm diameter Petri dish in TeSR-E8 basal
medium with 10 μM of Y-27632. On day −1, cells were transduced
with lentivirus FUW-M2rtTA and either Tet-O-Ngn2-puro or Tet-O-
Ngn2-puro-GFP with a total MOI of 50. On day 0, the culture medium
was replaced with N2B27 media containing 1:1 of Neurobasal medium
(NBM) and DMEM/F-12 supplemented with N2 supplement 1%, B27
Supplement Minus Vitamin A 1%, insulin/transferrin/selenium-A (ITS-
A) 1%, glucose 0.3%, glutamax supplement 1%, penicillin/strepto-
mycin 0.5% (all from Life Technologies) and doxycycline (1 μg/mL;
Sigma-Aldrich) to induce TetO gene expression. On day 2, puromycin
(3 μg/mL; Gibco) selection began. On day 5, surviving neural pro-
genitors were dissociated with StemPro Accutase Cell Dissociation Re-
agent (Life technologies) with DNase (0.1 mg/ml, Sigma-Aldrich) and
replated on poly-L-ornithine (0.1 mg/mL), laminin (10 μg/mL) and fi-
bronectin (10 μg/mL) (all from Sigma-Aldrich) triple-coated plastic
wells or glass coverslips at a density of 120,000 cells/cm2 in Neurobasal
medium supplemented with B27 2%, penicillin/streptomycin 0.5%,
ascorbic acid (200 μM; Sigma-Aldrich), DAPT (2.5 μM; Tocris), dox-
ycycline (1 μg/mL), and puromycin (3 μg/mL). On day 7, puromycin
was removed from the culture media. Media was changed every 2 days
and samples were collected on day 14 or day 21.
2.4. Differentiation prior to direct conversion
hESCs and two iPSCs (GBA-002-C3 and GBA-006-C6) were used for
patterning experiments. For forebrain patterning, cells were cultured in
N2B27 media and supplemented with SB431542 (SB; 10 μM, Tocris
Bioscience) and LDN193189 (LDN; 100 nM, Stemgent) for 6 days before
direct conversion, referred to as SB-LDN-NGN2. For hindbrain pat-
terning, N2B27 media was supplemented with 10 μM SB and
CHIR99021 (CHIR; 3 μM, Stemgent) for 4 days before direct conver-
sion, referred to as SB-CHIR-NGN2. Samples were collected on day 21
for immunostaining.
2.5. Immunolabeling
Cell culture dishes or coverslips were blocked for 1 h at room
temperature in blocking solution consisted of 5% donkey serum in PBT
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Fig. 1. Generation of induced neurons (iNs) by
direct conversion of human induced pluripotent
stem cells. (A) Schematic diagram of the induced
neuron protocol. DOX: doxycycline, PURO: pur-
omycin, AA: ascorbic acid. (B) Immnuostaining
of iNs on day 14 with different concentrations of
puromycin. Blue: DAPI, Green: RBFOX3, Red:
TUBB3. Arrowheads point to RBFOX3 positive
non-neuronal cells. Bar = 50 µm. (C)
Representative images of iNs with over-
expression of NGN2-EGFP and immunostaining
of neuronal markers MAP2 and TUBB3.
Bar = 50 µm. (D) The transduction efficiency of
the protocol (4 different cell lines) on day 14 and
day 21. (E) The maturation rate of iNs (4 dif-
ferent cell lines) on day 14 and day 21 by cal-
culating the MAP2-postive cells, compared to
DAPI staining. (F) The transduction and ma-
turation efficiency of iNs for the hESC line and
all of the hiPSC lines (12 different cell lines) on
day 21. Data are showed as the mean ± S.D
(n = 4).
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(PBS with 0.25% triton-X) solution. The following primary antibodies
were used: mouse anti-TUBB3 (Millipore, MAB1637: 1:1000), rabbit
anti-TUBB3 (Biolegend, 802001, 1:1000), mouse anti-NeuN (RBFOX3;
Millipore, MAB377, 1:500), chicken anti-MAP2 (Abcam, ab92434,
1:2500), guinea pig anti-synaptophysin 1 (Synaptic Systems, 101004,
1:1000), mouse anti -PSD95 (Abcam, ab2723, 1:500), rabbit anti-
vGLUT2 (SLC17A6; Synaptic Systems, 1:500), mouse anti-peripherin
(PRPH, Millipore, MAB1527, 1:500), rabbit anti-TBR1 (Abcam,
ab31940, 1:200), mouse anti-NEUROG3 (DSHB, F25A1B3, 1:4), sheep
anti-CHX10 (VSX2, Abcam, AB16141, 1:200), mouse anti-SHOX2
(Abcam, ab55740, 1:500). Antibodies were diluted in blocking solution
incubated on sections and cultures overnight at 4 °C. Following three
10-minute washes in PBT, the corresponding secondary antibodies were
applied for 1 h at room temperature. For mouse anti-PSD95 antibody,
second antibody was applied with biotin anti-mouse (Jackson
ImmunoResearch, 715-065-150, 1:200), followed by Alexa Fluor 488
Streptavidin (Jackson ImmunoResearch, 016-540-084, 1:1000). Nuclei
were counterstained with 4́, 6-diamidino-2-phenylindole (DAPI; 1 μg/
ml, Sigma). Slides were mounted in PVA-DABCO for viewing under a
fluorescent microscope (ZEISS ApoTome), and images captured using
the ZEN software. Confocal microscopy was performed using a ZEISS
LSM 780 Confocal Microscope.
2.6. Electrophysiology
For the electrophysiological recordings, iNs were replated on in-
dividual 13 mm coverslips (VWR, Ø 13 mm) on day 5 following an
additional 8 weeks of maturation time. The iNs on the coverslips were
transferred into a recording chamber and continuously perfused with
Artificial Cerebrospinal Fluid containing (in mM): NaCL 119, KCl 2.5,
NaHCO3 26, 1 NaH2PO4, D-glucose 11, CaCl2 2, MgCl2 2, adjusted to
pH 7.4 and bubbled with a mixture of CO2 (5%) and O2 (95%), at room
temperature. The chamber was mounted on an upright microscope
(Scientifica) linked to a digital camera (QImaging Exi Aqua) and the
cells were visualized using 63X water-immersion objective (Olympus).
Acquisitions were performed in a whole-cell configuration using
Clampex 10.6 software connected to a Multiclamp 700B amplifier via a
Digidata 1550A digitizer (all from Molecular Devices). Voltage-clamp
data were low-pass filtered at 200 Hz and digitized at 10 kHz and the
whole-cell capacitance was compensated. Patch pipettes (3–7 MΩ of
resistance) were filled with internal solution containing (in mM): K-
gluconate 170, Hepes 10, NaCl 5, KCl 10, EGTA 0.6, Na2GTP 2, and
NaGTP 0.3. The pH and osmolarity of the internal solution were close to
physiological conditions (pH 7.25, osmolarity 285 mOsm). The access
resistance of the cells in our sample was ~ 19 MOhm. Spontaneous
excitatory postsynaptic currents (sEPSC) were recorded in voltage-
clamp gap-free mode (clamped at −65 mV). Current-clamp mode was
used to analyse the intrinsic firing properties of the cell. Briefly, re-
petitive depolarizing current pulses (800 ms) of incremental amplitude
(10 pA) were used to determine the rheobase corresponding to the
minimum depolarizing current intensity needed to generate an action
potential (AP). Amplitude and spike-width of APs were measured on the
first AP at the rheobase level. Repetitively firing neurons were defined
as those capable of firing ≥ 3 APs in response to a depolarizing current
step. The amplitude of APs was measured from the point preceding the
fast rising phase of the spike to the peak of the spike, whereas APs
duration was defined as the width at half-maximal spike amplitude.
Data analysis was performed by Clampfit 10.6 (Molecular device). Data
are shown as the mean ± S.E.M.
2.7. RNA sequencing and analysis
For RNA sequencing, we used the hESC line and differentiated them
into the three iN groups NGN2, SB-CHIR-NGN2 and SB-LDN-NGN2 and
extracted RNA at day 21. RNA from undifferentiated hESCs were col-
lected and used as a control. Three biological replicates from each
group were collected, resulting in a total of 12 samples sequenced.
Specifically, RNA was extracted using RNeasy Mini Kit (Qiagen) fol-
lowing the manufacture’s instruction, and sent to BGI-China for mRNA
library construction, which consisted of mRNA enrichment by oligo dT
selection using magnetic beads. RNA was fragmented and reverse
transcribed to cDNA by N6 random primers. cDNA was amplified by
PCR and single-end sequencing performed with a minimum of 20 M
clean reads acquired per sample on a BGISEQ500 platform.
Bioinformatic analysis followed standard procedures of removing
adaptors, mapping to the reference human genome (hg19) using HISAT
and Bowtie2 tools, and differential gene expression detected using
DEseq2. For principal component analysis, the full transcriptomic pro-
file (21,774 genes) was included for analysis. Principal components
were calculated by singular value decomposition of the centred and
scaled data matrix using the prcomp function in R stats package.
Heatmaps were generated by log2 transforming and mean scaling FPKM
values of selected genes using heatmap.2 function in R stats package. A
Venn diagram was constructed using differentially expressed genes
(adjusted p-value lower than 0.05) identified by comparison of NGN2,
SB-LDN-NGN2 or SB-CHIR-NGN2 group to hESCs. Bar graphs of the top
10 significantly up/down-regulated genes present Log2 (Fold Change)
values of differentially expressed genes, identified by comparison of SB-
LDN-NGN2 or SB-CHIR-NGN2 group to NGN2. Threshold bar (white
line) indicates a fold change of ± 2. RNAseq data reported in this
paper is deposited in the Gene Expression Omnibus (GEO) with acces-
sion number GSE149864.
2.8. Multi-electrode array (MEA) recording and analysis
Three groups of iNs were plated on day 5 with a density of 100,000
cells/well on poly-L-ornithine (0.1 mg/mL), laminin (10 μg/mL) and
fibronectin (10 μg/mL) (all from Sigma-Aldrich) triple-coated 24-well
MEA plate (Multi Channel Systems MCS GmbH) in Neurobasal medium
supplemented with B27 2%, penicillin/streptomycin 0.5%, ascorbic
acid (200 μM; Sigma-Aldrich), DAPT (2.5 μM; Tocris), doxycycline
(1 μg/mL), and BDNF (20 ng/ml; R&D systems). Since there was no
obvious spontaneous activities detection on the day 21 culture for the
NGN2 group, human astrocytes (Sciencell) were added with a density of
25,000 cells/well to support the culture system for electrophysiological
recordings for the all the three groups. Spontaneous firing was recorded
for two minutes each time, twice a week for up to 10 weeks with
Multiwell-Screen software (Multi Channels Systems MCS GmbH).
Signals were sampled at 20 kHz and low-pass Butterworth filterer cutoff
was 3500 Hz and high-pass Butterworth filter cutoff was 100 Hz. Data
analysis were performed with Multiwell-Analyzer software (Multi
Channels Systems MCS GmbH). A spike detection was recorded when
signal exceeded a threshold of ± 5% of standard deviation of the
baseline noise during quiescent periods. A burst detection was recorded
following these settings: maximum interval to start and end burst was
50 ms; the minimum interval between bursts was 100 ms; the minimum
duration of burst was 50 ms, and there were more than 4 spikes counts
in a burst. A network burst detection was recorded when minimum 6
channels participating and minimum simultaneous channels are 3.
To investigate pharmacological effects, synaptic antagonists were
added to the neuronal culture media. The AMPA/kainite receptor an-
tagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo(f)quinoxaline-7-
sulfonamide (NBQX, 10 µM, Tocris) and sodium ion/channel antagonist
tetrodotoxin (TTX, 1 µM, Tocris) were added into separated MEA wells.
Spontaneous firing was recorded before and 30 mins after NBQX
treatment and 5 mins after TTX treatment.
3. Results
3.1. Direct conversion to iNs from human ESCs or iPSCs
Previous studies have demonstrated that direct conversion of hESCs
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or iPSCs into neurons can be achieved via a single proneural tran-
scription factor (Chanda et al., 2014; Goparaju et al., 2017). NeuroD1
or NGN2, are among the most potent; ASCL1, whilst also effective, has
been reported to have a slower conversion rate (Goparaju et al., 2017;
Zhang et al., 2013). We, therefore, selected NGN2 as the conversion
factor in our study and first sought to determine its robustness at
converting human iPSCs into neurons. By lentiviral delivery, we over-
expressed either NGN2 and Puromycin N-acetyl transferase or NGN2,
EGFP and Puromycin N-acetyl transferase; both constructs contain a
doxycycline inducible tetO promoter (Zhang et al., 2013). Two days
after lentiviral transduction, a high percentage of cells were EGFP po-
sitive, with only a few non-transduced EGFP negative cells present
(Supplementary Fig. 1A). Despite the high transduction rate, cells
without puromycin selection showed a vast difference in cellular mor-
phology by day 7 and only a few cells presented with a neuronal
morphology (Supplementary Fig. 1B). Conversely, after five days of
puromycin selection at 2 μg/ml, we observed an abundance of neurons;
intriguingly, however, RBFOX3 positive cells with a non-neuronal
morphology were present within these cultures (Fig. 1B). To prevent
the appearance of these non-neuronal cells, we first tested a range of
puromycin concentrations, up to 10 μg/ml. We determined that after
five days of puromycin selection, a concentration of 3 μg/ml was suf-
ficient to dramatically reduce the presence of non-transduced cells
(EGFP negative) and non-neuronal RBFOX3 positive cells in the culture
by day 7.
Secondly, we included a replating step to further enhance the purity
of converted cells (Supplementary Fig. 1C-D). The percentage of EGFP
positive cells at a replating density of 250,000 cells/cm2 on day 7 was
89.84%±4.13 S.D. Decreasing the plating density to 120,000 cells/
cm2 resulted in no detectable EGFP negative cells. By combining the
optimised puromycin concentration and replating density, we effi-
ciently and reproducibly converted all iPSC lines to neurons (Fig. 1C-F).
Across all the different lines, the percentage of transduced cells on day
14 and day 21 was above 97.93%±1.31 S.D (Fig. 1D). The neuronal
marker MAP2 increased slightly from day 14 to day 21, all lines were
above 89.51%±3.84 S.D at day 14, and above 95.06%±6.38 S.D at
day 21 (Fig. 1E).
3.2. Electrical activity of the converted neurons
Whole-cell electrophysiological recordings confirmed that the neu-
rons exhibited neuronal activity, indicative of mature, functional neu-
rons. At days 84–86, the recorded neurons showed sEPSC, with an
average amplitude of 46,0 ± 11,4 pA and a frequency of 20,4 ± 4,9
events per minute, confirming the formation of excitatory synapses
(Fig. 2A). The cells’ intrinsic membrane properties were also measured
as an indication of a functional maturation: the membrane resistance
was 500,8 ± 138,2 MOhm, and mean capacitance was 39.90 ± 5.28
pF (Fig. 2B). We then asked if the cells were able to fire action poten-
tials (APs) in response to the injection of current, and observed that
repetitive firing can be induced in sufficiently depolarized cells. In our
experiment, the injected current necessary to induce a first AP (i.e,
rheobase, red trace) was 27.5 ± 6.3 pA (Fig. 2C). The rheobase was
directly linked to the resting membrane potential of the cell (Vm). At
days 84–86, the Vm of our recorded cells was −50,5 ± 4,1 mV
(Fig. 2D). Detailed analysis of AP properties revealed a mature shape of
the APs, with a discharge threshold (APthresh) of−31.6 ± 1.9 mV, AP
amplitude averaged 38.5 ± 8.0 mV, and a half-width of 6.5 ± 1.7 ms
(Fig. 2D). Finally, we saw that the cells responded by an increase in the
number of APs to an increment of the amplitude of the current injected
(Fig. 2D).
3.3. Combining differentiation and direct conversion to generate pure CNS
neurons
Having optimised an efficient neuronal conversion method, we then
further characterised the types of neurons generated from the Ngn2-
conversion protocol. In agreement with our electrophysiological re-
cordings, the iNs displayed punctate staining for both synaptophysin
(SYP) and postsynaptic protein PSD-95, which indicates synaptic ma-
turity (Fig. 3A). Furthermore, we observed the expression of neuronal
marker RBFOX3 (Fig. 3B) and glutamate transporter SLC17A6
(VGLUT2) in the neurons (Fig. 3C). We could not detect GABA or TH-
positive neurons, or astrocytes (GFAP-positive; data not shown), al-
though interestingly, a population of peripheral neurons was observed
in the cultures (Fig. 3D). The percentage of PRPH+/DAPI neurons was
9.40% (±3.29 S.D), 10.24% (±3.05 S.D), and 9.20% (±3.55 S.D)
across three different cell lines.
To prevent the presence of peripheral neurons, we incorporated a
short differentiation step before the direct conversion protocol
(Fig. 4A). Two differentiation methods were developed that patterned
the hESCs/iPSCs into neural progenitors of either the forebrain or
hindbrain. For forebrain specification we patterned the cells with
SB431542 and LDN193189 referred to as SB-LDN-NGN2 and for hind-
brain patterning we used SB431542 and CHIR99021, referred to as SB-
CHIR-NGN2. Previously, we reported both of these patterning methods
to successfully differentiate iPSCs to NSCs of these regions (Chen et al.,
2018; Denham et al., 2015, 2012). Regardless of the patterning, upon
neuronal conversion and selection, the two new protocols produced
neurons with high efficiency similar to the NGN2 group. We next used
RNAseq to determine how the patterning had altered their neuronal
identity. Firstly, gene expression from all the samples was normalized
and compared using principal component analysis (Fig. 4B). We ob-
served that PC1 had the highest variance (50.7%) and revealed a clear
separation between the undifferentiated stem cell state and the neu-
ronal groups, whereas PC2 could separate the neuronal groups based on
anterior-posterior identity: the SB-CHIR-NGN2 group separated from
the NGN2 and SB-LDN-NGN2 groups with a variance of 18.1%. Within
the four groups, we compared the expression of pluripotent genes
(Fig. 4C). We observed that the pluripotent genes NANOG and POU5F1,
as well as SOX2, were highly expressed in the hESCs group, but not in
the three iN groups. Secondly, we examined the gene expression of
neuronal lineage markers (Fig. 4D). As expected, all the three direct
conversion groups, when compared to hESCs, expressed high levels of
the mature neuronal markers SYP, DLG4, and MAP2, as well as higher
levels of neuronal lineage markers (Fig. 4D). Uniquely to the NGN2
group, a high level of the peripheral neuronal marker PRPH was ob-
served (Fig. 4D), which is in accordance with our immunostaining re-
sults (Fig. 3D). The inclusion of a patterning step, for both SB-LDN and
SB-CHIR, significantly reduced the PRPH transcript levels (−4.14 log2
fold change of SB-LDN vs. NGN2 at a padj = 2.11 × 10−185 and−5.09
log2 fold change of SB-CHIR vs. NGN2 at a padj = 2.96 × 10−233) and
no PRPH positive cells could be identified by immunostaining in the SB-
LDN or SB-CHIR groups (Supplementary Fig. 2). Compared to hESCs, all
iN groups expressed significantly higher vesicular glutamate trans-
porter SLC17A7 (SB-LDN padj = 3.50 × 10−38 and SB-CHIR
padj = 1.77 × 10−39) and SLC17A6 (SB-LDN padj = 1.02x10-282 and
SB-CHIR padj = 4.12x10-143) levels, while very few transcripts were
detected for GABA transporter SLC6A1 in SB-CHIR-NGN2 and SB-LDN-
NGN2 groups, and no detectable transcripts were identified in any of
the groups for GAD1 and GAD2 (< 1 FPKM).
We next examined the expression of anterior-posterior neuronal
markers and forebrain markers. The SB-LDN-NGN2 group expressed the
highest level of SIX3 and FOXG1 (Fig. 4C). The forebrain/midbrain
marker OTX2 was also higher in SB-LDN-NGN2 group, compared to
NGN2 group and SB-CHIR-NGN2 group. At the midbrain level, the
markers EN1 and PAX5 were not detected in any of the groups, and only
very few transcripts for PAX2 were detected in the NGN2 group (1.24
FPKM). At the hindbrain level, the SB-CHIR-NGN2 group expressed the
highest level of HOXA1 and HOXA2 (Fig. 4C). For cervical, thoracic,
lumbar and sacral markers; no transcripts were detected in the four
groups. Gene expression comparisons showed that all three direct-
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converted groups shared 7650 genes (out of 12,264 genes) and, in ac-
cordance with PCA analysis, the SB-CHIR-NGN2 group contained the
most unique genes (1793) from the other two neuronal populations,
which accords with its more distinct hindbrain identity (Fig. 4E). The
most differentially expressed genes were identified by direct compar-
ison between the SB-CHIR-NGN2 group and the NGN2 group, as well as
between the SB-LDN-NGN2 group and the NGN2 group (Fig. 4F). Of
significance, in the SB-CHIR-NGN2 group, VSX2 (previously known as
CHX10), NEUROG3, POU3F1, and SHOX2 were highly upregulated,
while in the NGN2 group, ISL1, NEUROG2 and PRPH were highly up-
regulated. In the SB-LDN-NGN2 group, SIX3 and FOXG1 were among
the most differentially expressed genes (Fig. 4F). Overall, the results of
the RNAseq analysis revealed that the SB-LDN-NGN2 group resulted in
a forebrain cortical neuron identity, and that the SB-CHIR-NGN2 group
resulted in a hindbrain identity.
VSX2 and SHOX2 are both expressed in V2a interneurons, and both
genes were highly expressed in the SB-CHIR-NGN2 group. V2b inter-
neurons that express GATA3 are closely related to V2a interneurons,
but GATA3 was not detected in any of the groups. We were therefore
interested in confirming the presence of V2a interneurons within the
SB-CHIR-NGN2 group and, by immunostaining, we readily observed
VSX2 and SHOX2 double-positive cells (Fig. 4G), with an efficiency of
43.17%±16.81 S.D, 45.83%±2.93 S.D, and 43.07%±8.97 S.D
((VSX2+SHOX2+)/DAPI)% for V2a interneurons converted from
hESCs, GBA-006-C6, and GBA-002-C3 respectively. Immunostaining
also confirmed that NEUROG3-positive cells featured prominently in
SB-CHIR-NGN2, but not in NGN2 and SB-LDN-NGN2 (Fig. 4H). In the
SB-LDN-NGN2 group, only a few SHOX2-positive neurons were ob-
served and no VSX2-positive neurons were found. In the NGN2 group,
neither VSX2 nor SHOX2 neurons were observed (Fig. 4G). Ad-
ditionally, RNA in situ images (from the Allen Developing Mouse Brain
Atlas in E11.5) of mouse embryos were used to confirm the spatial lo-
cation of Vsx2, Neurog3, and Shox2, which identified these markers to
be expressed in the ventral hindbrain and spinal cord, where V2a in-
terneurons are located (Supplementary Fig. 3).
In the SB-LDN-NGN2 group, TBR1 expression levels were sig-
nificantly higher than in any of the other groups. To confirm its ex-
pression, we examined all neuronal conversion groups by im-
munostaining. We identified TBR1 in both the NGN2 and SB-LDN-
NGN2 groups and not in the SB-CHIR-NGN2 group (Fig. 5). For the SB-
LDN-NGN2 group, the efficiency of (TBR1+/DAPI)% was
65.55%±4.16 S.D for hESCs and 62.84%±6.68 S.D for GBA-002-C3.
Fig. 2. Electrophysiological properties of iNs from iPSCs. (A) Representative trace of spontaneous excitatory postsynaptic currents (sEPSC, black stars) recorded at a
holding potential of −65 mV in ACSF, with the amplitude and the frequency of the events. (B) Intrinsic membrane properties represented by the input resistance and
the membrane capacitance (Cm). (C-D) Firing properties. (C) Representative traces of APs generated in response to a depolarizing current (lower trace). The rheobase
(red trace) represent the injected-current necessary to induce the first APs. (D) The discharge threshold (APtresh.), the APs amplitude (APampl.), and the APs width
were measured from the first evoked spike at the rheobase level. The number of APs was counted after each amplitude increment of step-current stimulation. Values
are given as the mean ± S.E.M (n = 4).
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3.4. Electrophysiological activity and functionality of the three iN groups by
MEA
We used MEA to examine the electrophysiological activity of the
neurons in all the three groups. We detected neural activity, recorded as
spikes, first in the SB-CHIR-NGN2 group on day 16, and bursts and
network bursts were seen on day 23. Following this, in the SB-LDN-
NGN2 group, bursts were detected on day 30 and network bursts on day
54. The NGN2 group was the last group to show bursts (on day 33) with
no network bust detection throughout the 65 days culture. On day 49,
the SB-CHIR-NGN2 group showed a synchronized network burst with
voltage around 400 µV. The SB-LDN-NGN2 group had network bursts
with voltage around 50 µV. The NGN2 group had bursts but not net-
work burst with the voltage around 30 µV (Fig. 6).
All the three iN groups responded to the treatment of AMPA/kainite
glutamate receptor antagonist NBQX. The spontaneous firing decreased
dramatically for both SB-CHIR-NGN2 and SB-LDN-NGN2 groups, while
there were still some firing signals for the NGN2 group. With TTX
treatment, the firing was eliminated from all the three groups
(Supplementary Fig. 4).
4. Discussion
In this study, we established a robust and rapid protocol for gen-
erating regionally specified iNs from human iPSCs by combining a short
patterning step with a direct conversion approach. We started out by
examining the previously described NGN2-puromycin method, which
has been shown capable of rapidly converting human iPSCs and hESCs
into excitatory neurons with a cortical identity (Zhang et al., 2013). We
determined that, in order to achieve a highly pure population of
neurons, and to overcome variability in efficiencies between experi-
ments and individual hiPSC lines, we needed to make several important
modifications to the existing protocol.
We first optimised the concentration and duration of puromycin, as
well as including a cell-replating step that further removed any re-
maining non-selected cells and dead cells and allowed for neurons to be
replated at a consistent density, which was essential for the downstream
transcriptomics and also provided a scalable and standard platform for
converting numerous iPSCs lines in parallel.
After implementing these modifications, the percentage of trans-
duced cells was above 97.93% (±1.31) on day 14 and day 21, and the
percentage of cells expressing the mature neuronal marker MAP2 was
above 95.06% (±6.38) (Fig. 1). Furthermore, we demonstrated that
the neurons were synaptically mature: the 21-day culture contained
SYP-positive synaptic punctate and PSD95 (Fig. 3A), and patch-clamp
electrophysiology showed that neurons exhibited mature functional
activity at 12 weeks of culture (Fig. 2). Overall, our replating step and
puromycin optimisation successfully overcame the problem of cell line
variability, ensured a consistent neuronal density at the end-point for
all iPSC lines used, and resulted in functionally active neurons without
the need to supplement the cultures with astrocytes, which thus en-
sured that the transcriptome analysis was purely from converted neu-
rons.
Close examination of our NGN2 converted neurons revealed that
peripheral neurons were present within the culture (Fig. 3D). To ad-
dress this heterogeneity, we made a second modification to the pro-
tocol: we combined a differentiation/patterning step with the conver-
sion to generate pure CNS neurons. Previous research has shown that
hESCs can be patterned towards a forebrain identity with SMAD in-
hibition or towards a hindbrain fate by SMAD inhibition and activation
Fig. 3. Characterization of the iNs by immunostaining on day 21. (A) Representative images of DAPI, PSD95, and synaptophysin1 (SYN) staining. Bar = 2 µm. (B)
Representative images of DAPI, RBFOX3 (NEUN), and MAP2 staining. Bar = 10 µm. (C) Representative images of DAPI and SLC17A6 (vGlut2) staining. Bar = 10 µm.
(D) Representative images of DAPI, GFP, and PRPH staining. Arrowheads point to PRPH positive neurons. Bar = 10 µm.
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of WNT signalling (Denham et al., 2015). We examined the effect of
combining either of these two differentiation protocols with the NGN2-
conversion approach. Our RNA sequencing analysis showed that both
patterning steps, when followed by direct conversion, completely
eliminated the presence of peripheral neurons (Fig. 4B). Additionally,
the identity of the converted neurons was differentially altered ac-
cording to the extrinsic patterning. We observed that SB-LDN pat-
terning, when combined with NGN2 conversion, was an effective
strategy for generating an enriched culture of forebrain cortical neu-
rons. Both SB-LDN-NGN2 and NGN2 conditions converted hESCs to-
wards a cortical identity (Fig. 4B, D), however, SB-LDN patterning
produced a more pure population of forebrain neurons, whereas the
NGN2 alone could also produce peripheral neurons (Fig. 3D); RNAseq
analysis revealed expression of genes representative of broader brain
regions (Fig. 4C). In accordance with this, the gene expression of
forebrain markers SIX3 and FOXG1 in the SB-LDN-NGN2 group was
significantly higher than in the NGN2 group, and the SB-LDN-NGN2
group had no detectable levels of the midbrain markers PAX2, PAX5 or
EN1 (Fig. 4C).
Patterning of hESCs/iPSCs into hindbrain progenitors by treatment
with SB431542 and CHIR for 4 days, followed by NGN2 conversion,
generated anterior hindbrain excitatory neurons (Fig. 4). VSX2 was
seen to be significantly upregulated in the SB-CHIR-NGN2 group and
we could detect an abundance of these neurons within the culture
(Fig. 4G). VSX2 is a transcription factor and, within the hindbrain and
spinal cord, it is specific to V2a interneuron (Al-Mosawie et al., 2007;
Clovis et al., 2016; Li et al., 2005; Lundfald et al., 2007). To further
confirm the identity of the interneuron, we examined the expression of
SHOX2 by immunostaining, which co-localized with VSX2. Sig-
nificantly more transcripts for SHOX2 were also detected in the SB-
CHIR-NGN2 group. Interestingly, we observed that not all VSX2 inter-
neurons expressed SHOX2. Neurons double-positive for VSX2 and
SHOX2 are known to be excitatory interneurons that control motor
neurons, while the VSX2+SHOX2- activate the commissural pathways
involved in left–right coordination. (Dougherty et al., 2013; Ha and
Dougherty, 2018).
A recent study demonstrates that V2a interneurons can be differ-
entiated from human PSCs by dual SMAD inhibition, followed by re-
tinoic acid and low concentrations of a Smoothened agonist, and Notch
inhibition (Butts et al., 2017). By contrast, we obtained V2a inter-
neurons without the inclusion of extrinsic factors to specifically activate
the SHH pathway, which suggests that some basal plate SHH targets
may be activated directly by the NGN2 conversion. In accordance with
this, Ngn2 is regionally expressed in the basal plate of the developing
mouse spinal cord and has been shown to be involved in regulating the
expression of ventral transcription factors (Scardigli et al., 2001). The
neuralizing transcription factor in direct conversion protocols may
therefore also influence the neuronal subtypes generated. Furthermore,
in direct conversion experiments NGN2 has been shown to pre-
ferentially give rise to excitatory neurons. As expected, by inhibiting
the AMPA receptor, we found that indeed excitatory neurons were the
main neuronal cell type present in all of our iN groups (Fig. 6 and
Supplementary Fig. 4).
The Notch pathway has previously been shown to control the spe-
cification between V2a and V2b interneurons, with Notch inhibition
specifying V2a over V2b interneurons (Del Barrio et al., 2007; Peng
Fig. 4. Combining CNS patterning and direct conversion to generate pure CNS neurons. (A) Flow diagram of combining CNS patterning before the direct conversion
protocol. (B) Principal component analysis shows a separation of the iNs groups from the undifferentiated stem cell state on PC1 and a separation of the iNs groups
based on anterior-posterior identity on PC2. (C) Gene expression of known markers indicative of the pluripotent, anterior, and posterior patterning. (D) Gene
expression of known markers indicative of neuronal lineages. (E) Schematic Venn diagram showing the overlap of genes within the three iNs groups. (F) The top 10
and selected additional (bold) downregulated (blue) and upregulated (red) genes in the CNS pre-patenting groups, versus the NGN2 group. Threshold bar (white line)
indicates a fold change of± 2. (G) Representative images of DAPI, VSX2, SHOX2 and TUBB3 staining. Arrowheads point to VSX2 and SHOX2 double positive cells.
Bar = 10 µm. (H) Representative images of DAPI, TUBB3 and NEUROG3 staining. Bar = 20 µm. RNAseq data were from hESCs and hESC-derived iNs, im-
munostaining results were represented images from iNs converted from hESCs and two iPSCs lines.
Fig. 5. The gene expression profile and immunostaining images of cortical marker TBR1. (A) Expression level profiling of cortical marker, TBR1 in hESC, NGN2, SB-
CHIR-NGN2 and SB-LDN-NGN2 groups. FPKM + 1 values log2 transformed and plotted as mean with S.D, n = 3. (B) Representative images of DAPI, TUBB3, and
TBR1 staining. Arrowheads point to representative TBR1 positive cells. Bar = 10 µm.
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et al., 2007). In all of our iN groups, we could not detect GATA3 ex-
pression, a marker of V2b interneurons. DAPT was also included during
the NGN2 conversion, to enhance neuronal conversion, which in com-
bination with NGN2 likely helped promote the specification of V2a over
V2b cell types. This suggests that the influence of patterning factors,
specifically DAPT, on the neuronal subtypes would also be effective
during the later NGN2 conversion phase. Indeed, simultaneous pat-
terning and neuronal conversion from either fibroblasts or iPSCs can
result in a more robust conversion and with the inclusion of dual SMAD
factors and WNT antagonists enhance the specification of forebrain
neurons (Ladewig et al., 2012; Nehme et al., 2018).
In conclusion, we demonstrated that sequential patterning and
neuronal conversion of human PSCs is a highly successful method for
manipulating the identity of the neurons with the ability to regionally
specify them along the rostral caudal axis, which results in a more
defined population of neurons. This approach can be used for
Fig. 6. Electrophysiological activities of the three iN groups by multi-electrode array (MEA). Raster plots of spontaneous activities for 2 mins (left, x axis is time and y
axis is channel ID) and 30 s (right, numbers in the corners of boxed plots are the channel IDs) of raw data from the representative electrodes on week 7. Each black
line represents a spike detection. Each red line represents a single channel burst (a collection of at least 4 spikes). Each blue line represents a network burst detection
(with minimum of 50% of participating electrodes across entire well and minimum 25% of simultaneous channels). The images on the right side were 30 s recording
from the left (marked with black rectangles).
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investigating a range of neurological disorders such as AD, MND or
spinal cord injury.
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